AZ says its COVID-19 vaccine protects against severe disease caused by variants
Real-world data shows jab is effective after one dose against hospitalisation/death caused by Beta and Delta variants
Read More
Tag: Vaxzevria
- Tremfya data show sustained remission in ulcerative colitis through 3 years
- Brensocatib becomes first licensed treatment for non‑cystic fibrosis bronchiectasis
- Lario Therapeutics awarded $2.4m to advance calcium channel platform
- Mikrobiomik secures approval for gut‑microbiota therapy for C difficile infection
- Exdensur approved in EU for severe asthma and CRSwNP
